John Overdeck’s Oragenics OGEN Stock Holding History

John Overdeck’s Portfolio OGEN Stock Details OGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-608	Closed	-$3.83K	–	3429
2025 Q1	$3.83K	Sell	608 -48	-7%	-$415	﹤0.01%	3152
2024 Q4	$7.26K	Buy	+656	New	+$6.72K	﹤0.01%	3140

Other funds holding OGEN

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

LWM

Lionsbridge Wealth Management Jacksonville Beach, Florida $102M AUM 28.57% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return

John Overdeck's OGEN Position: Q2 2025 in Review

John Overdeck sold out of Oragenics (OGEN) in Q2 2025, closing a stake of 608 shares — an estimated $3.83K sold.

John Overdeck first reported a position in OGEN in Q4 2024 and held it in 2 quarters. The position peaked at $7.26K in Q4 2024. 18 funds tracked by Wall St. Rank hold OGEN as of Q2 2025.

John Overdeck reported no remaining Oragenics position as of Q2 2025 after selling out during the quarter.
John Overdeck sold 608 Oragenics shares in Q2 2025, an estimated $3.83K.
John Overdeck first reported a position in Oragenics in Q4 2024 and held it in 2 quarters.
John Overdeck's Oragenics position peaked at $7.26K in Q4 2024.
18 funds tracked by Wall St. Rank held Oragenics as of Q2 2025.

Based on Two Sigma Investments's 13F filing for Q2 2025, filed 14 Aug 2025.